Lv4
586 积分 2025-01-23 加入
Risk factors for pancreatic cancer: a summary review of meta-analytical studies
2天前
已完结
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
3天前
已完结
Pancreatic cancer
4天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
6天前
已完结
Less is more: Exploring neoadjuvant immunotherapy as a de-escalation strategy in head and neck squamous cell carcinoma treatment
9天前
已完结
Head and Neck Cancer
9天前
已完结
Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients
9天前
已完结
Locoregionally advanced nasopharyngeal carcinoma: integrating immunotherapy into definitive treatment
10天前
已关闭
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
12天前
已完结
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
13天前
已完结
皖公网安备34019202002308
